Ramida Affirms Saudi Pharma Project

Ramida, the 10th of Ramadan Pharmaceuticals Industries Company, has confirmed its expansion plans in the Saudi market through the establishment of a pharmaceutical factory in collaboration with LV Pharma. This move aligns with its strategic efforts previously announced in June 2026, after LV Pharma increased its stake in Ramida to 31.49% by purchasing approximately 167 million shares valued at around 846.5 million Egyptian pounds. The company will announce full details once all the necessary implementation procedures for the project are completed.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل